NO20055227L - Stamceller med okt sensitivitet for en kjemoattraktant og fremgangsmater for fremstilling og anvendelse derav - Google Patents

Stamceller med okt sensitivitet for en kjemoattraktant og fremgangsmater for fremstilling og anvendelse derav

Info

Publication number
NO20055227L
NO20055227L NO20055227A NO20055227A NO20055227L NO 20055227 L NO20055227 L NO 20055227L NO 20055227 A NO20055227 A NO 20055227A NO 20055227 A NO20055227 A NO 20055227A NO 20055227 L NO20055227 L NO 20055227L
Authority
NO
Norway
Prior art keywords
chemoattractant
methods
stem cells
increased sensitivity
preparation
Prior art date
Application number
NO20055227A
Other languages
English (en)
Inventor
Tsvee Lapidot
Orit Kollet
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL15530303A external-priority patent/IL155303A0/xx
Priority claimed from IL15930703A external-priority patent/IL159307A0/xx
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of NO20055227L publication Critical patent/NO20055227L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/12—Hepatocyte growth factor [HGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Developmental Biology & Embryology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Den foreliggende oppfirmelsen angår stamceller som har økt sensitivitet for en kjemoattraktant og nærmere bestemt, fremgangsmåter og anvendelser derav, slik som irmen kliniske bruksområder som omfatter stamcelletransplantasjon.
NO20055227A 2003-04-08 2005-11-07 Stamceller med okt sensitivitet for en kjemoattraktant og fremgangsmater for fremstilling og anvendelse derav NO20055227L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL15530303A IL155303A0 (en) 2003-04-08 2003-04-08 Stem cells having increased sensitivity to a chemoattractant and methods of generating and using same
IL15930703A IL159307A0 (en) 2003-12-10 2003-12-10 Stem cells having increased sensitivity to a chemo-attractant and methods of generating and using same
PCT/IL2004/000315 WO2004090121A2 (en) 2003-04-08 2004-04-07 Stem cells having increased sensitivity to a chemoattractant and methods of generating and using same

Publications (1)

Publication Number Publication Date
NO20055227L true NO20055227L (no) 2005-11-07

Family

ID=33161264

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055227A NO20055227L (no) 2003-04-08 2005-11-07 Stamceller med okt sensitivitet for en kjemoattraktant og fremgangsmater for fremstilling og anvendelse derav

Country Status (8)

Country Link
US (1) US8029780B2 (no)
EP (1) EP1613742A2 (no)
JP (2) JP4865541B2 (no)
AU (1) AU2004227205B2 (no)
CA (1) CA2519975C (no)
IL (2) IL171254A (no)
NO (1) NO20055227L (no)
WO (1) WO2004090121A2 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101495623B (zh) 2006-03-24 2013-09-11 儿童医疗中心有限公司 调节造血干细胞生长的方法
US9402852B2 (en) 2006-10-20 2016-08-02 Children's Medical Center Corporation Method to enhance tissue regeneration
WO2008073748A1 (en) 2006-12-08 2008-06-19 University Of Rochester Expansion of hematopoietic stem cells
US20110165128A1 (en) * 2008-03-07 2011-07-07 Columbia University In The City Of New York Homing in mesenchymal stem cells
CN102245758A (zh) 2008-11-06 2011-11-16 印第安纳大学研究与技术公司 增强造血干细胞植入过程的材料和方法
SG10201602423TA (en) 2011-09-30 2016-05-30 Bluebird Bio Inc Compounds For Improved Viral Transduction
JP6220791B2 (ja) 2011-12-02 2017-10-25 フェイト セラピューティクス，インコーポレイテッド 増強された幹細胞組成物
US10162168B2 (en) 2013-05-03 2018-12-25 Wilcox Industries Corp. Binocular bridge for thermal viewing device
WO2017139561A1 (en) 2016-02-12 2017-08-17 Bluebird Bio, Inc. Vcn enhancer compositions and methods of using the same

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622853A (en) * 1990-05-01 1997-04-22 Becton Dickinson And Company T lymphocyte precursor
ES2143990T3 (es) * 1991-07-26 2000-06-01 Toray Industries Utilizacion de factores de crecimiento de hepatocitos para la fabricacion de un multiplicador de celulas cepa hematopoyeticas.
DE4422667A1 (de) * 1994-06-30 1996-01-04 Boehringer Ingelheim Int Verfahren zur Herstellung und Züchtung hämatopoetischer Vorläuferzellen
IT1271088B (it) * 1994-11-24 1997-05-26 Dompe Spa Uso di fattore di crescita degli epatociti per indurre la proliferazione e differenziazione di cellule emopoietiche
US6248722B1 (en) * 1995-08-29 2001-06-19 Sumitomo Pharmaceuticals Company, Limited Medicament comprising HGF gene
JPH10295369A (ja) * 1997-02-26 1998-11-10 Japan Tobacco Inc 造血幹細胞の製造方法
CA2304961A1 (en) * 1997-09-25 1999-04-01 Glycotech Corporation Methods and compositions for binding hematopoietic stem cells
JP3962459B2 (ja) * 1997-10-28 2007-08-22 麒麟麦酒株式会社 造血幹細胞の分化・増殖調節方法
US6586192B1 (en) * 1998-05-29 2003-07-01 Thomas Jefferson University Compositions and methods for use in affecting hematopoietic stem cell populations in mammals
IL125532A0 (en) * 1998-07-27 1999-03-12 Yeda Res & Dev Hematopoietic cell composition for use in transplantation
US6642049B1 (en) * 1998-12-04 2003-11-04 The United States Of America As Represented By The Secretary Of The Navy Human brain endothelial cells and growth medium and method for expansion of primitive CD34+CD38-bone marrow stem cells
AU759719B2 (en) * 1999-02-04 2003-04-17 Pluristem Ltd. Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells
AU2001280149A1 (en) * 2000-08-25 2002-03-04 Asahi Kasei Kabushiki Kaisha Stem cell culture medium and culture method by using the same
GB0031390D0 (en) * 2000-12-21 2001-02-07 Imp College Innovations Ltd Methods
CA2442177A1 (en) * 2001-03-29 2002-10-10 Ixion Biotechnology, Inc. Method for transdifferentiation of non-pancreatic stem cells to the pancreatic differentiation pathway
EP2322618A1 (en) * 2001-07-10 2011-05-18 Johnson & Johnson Research Pty Limited Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells

Also Published As

Publication number Publication date
IL200207A (en) 2012-06-28
WO2004090121A3 (en) 2004-12-29
US8029780B2 (en) 2011-10-04
IL200207A0 (en) 2011-08-01
US20070172464A1 (en) 2007-07-26
JP2006522604A (ja) 2006-10-05
EP1613742A2 (en) 2006-01-11
CA2519975C (en) 2013-07-02
IL171254A (en) 2013-06-27
WO2004090121A2 (en) 2004-10-21
JP5362659B2 (ja) 2013-12-11
AU2004227205A1 (en) 2004-10-21
JP4865541B2 (ja) 2012-02-01
JP2010263907A (ja) 2010-11-25
IL171254A0 (en) 2011-08-01
CA2519975A1 (en) 2004-10-21
AU2004227205B2 (en) 2010-06-10

Similar Documents

Publication Publication Date Title
NO20055227L (no) Stamceller med okt sensitivitet for en kjemoattraktant og fremgangsmater for fremstilling og anvendelse derav
NO20062709L (no) Stamceller som er egnet for transplantasjon, fremstilling derav og farmasoytiske preperater omfattende nevnte stamceller
NO2019004I1 (no) patisiran: dekket gjennom sekvensene i kravene 1, 8 og 9 (se særlig krav 8 (b) og (c) i patentet. Det vises også til følgebrevet til søknaden.
NO20080067L (no) Polypeptider som har antimikrobeaktivitet og polynukleotider som koder for disse
NO20083153L (no) Kjemiske forbindelser
NO20055211L (no) Anti-fungale forbindelser og fremgangsmater for anvendelse
NO20062649L (no) Biarylsulfonamider og metoder for anvendelse av disse
TW200621253A (en) 2-amido-thiazole-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof
TW200614966A (en) Analyte monitoring system with wireless alram
DK1954811T3 (da) Inducerbare ekspressionssystemer
AR056256A1 (es) Plantas resistentes al estres
BRPI0414593A (pt) derivados de ácido sulfonamida substituìda-indol-2-carboxìlico como inibidores de pai-1
NO20083324L (no) Multisykliske aminosyrederivater og anvendelse derav
NO20076001L (no) Tigecyklin og metoder for deres fremstilling
NO20091509L (no) Substituerte tetrahydropyrrolopyrazinforbindelser med affinitet KCNQ2/3 K+ kanal og anvendelse derav i medikamenter
DK1768490T3 (da) Systemer og fremgangsmåder til ex-vivo-organpleje
WO2004087758A3 (en) Il 13 receptor alpha 2 antibody and methods of use
ATE427965T1 (de) Antikírper gegen 25-hydroxyvitamin d
BRPI0414599A (pt) pirrol-indóis substituìdos
NO20071840L (no) Ikke-peptid bradykininantagonister og farmasoytiske sammensetninger derav.
NO20064715L (no) Deteksjon, isolering og anvendelse av renalase (monoamin aksidase C)
CY1112877T1 (el) Μεταλλαγματα αυξητικου παραγoντα υψηλης δραστικοτητας
NO20081470L (no) Polypeptider som har antimikrobeaktivitet og polynukleotider som koder for disse.
NO20075227L (no) Treatment of eczemas
NO20062022L (no) 1-(kinolinamino)- og 1-(isokinolinamino)-substituerte pentan-2-oler, fremgangsmate for fremstilling av disse og anvendelse av den som antiinflammatoriske midler